This site is intended for health professionals only.
The Pharmacist
  • Newsletter sign-up
  • My Account
  • Log In
  • News
  • Community
    • Interviews
    • Views
    • Analysis
  • In Practice
    • Interviews
    • Views
    • Analysis
  • Clinical
    • Cancer
    • Cardiovascular
    • Dermatology and wound care
    • Diabetes and endocrinology
    • Mental health and addiction
    • Musculoskeletal and rheumatology
    • Men's health
    • Neurology
    • Nutrition and gastroenterology
    • Paediatrics
    • Pain
    • Respiratory
    • Renal and urology
    • Sexual health
    • Vaccinations and infections
    • Women's health
    • All clinical
  • Pharmacy First
  • Clinical Ambassadors
    • Healthy living
    • Men's health
    • Minor ailments
    • Pain management
    • Seasonal health
    • Skincare
    • Travel health services
    • Vaccination
    • Women's health
    • All services
  • Investigations
  • Events
  • News
  • Community
    • Interviews
    • Views
    • Analysis
  • In Practice
    • Interviews
    • Views
    • Analysis
  • Clinical
    • Cancer
    • Cardiovascular
    • Dermatology and wound care
    • Diabetes and endocrinology
    • Mental health and addiction
    • Musculoskeletal and rheumatology
    • Men's health
    • Neurology
    • Nutrition and gastroenterology
    • Paediatrics
    • Pain
    • Respiratory
    • Renal and urology
    • Sexual health
    • Vaccinations and infections
    • Women's health
    • All clinical
  • Pharmacy First
  • Clinical Ambassadors
    • Healthy living
    • Men's health
    • Minor ailments
    • Pain management
    • Seasonal health
    • Skincare
    • Travel health services
    • Vaccination
    • Women's health
    • All services
  • Investigations
  • Events
  1. Home
  2. Tirzepatide

Topic: Tirzepatide

Latest

Government enters ‘strategic collaboration’ with tirzepatide obesity drug maker

Government enters ‘strategic collaboration’ with tirzepatide obesity drug maker
NICE recommends tirzepatide for NHS primary care
Clinical

NICE recommends tirzepatide for NHS primary care

7th June 2024

Notification issued for multiple GLP1-RA shortages
Clinical

Notification issued for multiple GLP1-RA shortages

19th March 2024

Mounjaro weight loss service hoped to ease supply issues
Clinical

Mounjaro weight loss service hoped to ease supply issues

16th February 2024

Tirzepatide approval sparks hope though supply warnings remain
Clinical

Tirzepatide approval sparks hope though supply warnings remain

11th September 2023

Most popular
1
Two batches of paracetamol recalled due to ‘contamination’
2
Nystan oral suspension discontinued
3
Halt to new distance selling pharmacies
4
ARRS pharmacists entitled to 3.6% pay rise for 2025/26
FOLLOW US

IMPORTANT LINKS

  • Subscribe to newsletters
  • Contact us
  • Privacy policy
  • Terms and conditions
  • Yellow Card reporting

MORE FROM COGORA

  • Pulse Today
  • Pulse PCN
  • Nursing In Practice
  • Management In Practice
  • Healthcare Leader
  • Hospital Healthcare Europe
  • Hospital Pharmacy Europe

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
Search
The Pharmacist
The Pharmacist newsletters

Sign up today to receive the latest daily political, business, and clinical news in the pharmacy sector.

Subscribe